Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Batch Record Review for Gels – V 2.0

Posted on By

Gel Manufacturing: SOP for Batch Record Review for Gels – V 2.0

Standard Operating Procedure for Reviewing Batch Records in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/081/2025
Supersedes SOP/GM/081/2022
Page No. Page 1 of 11
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To establish a standard procedure for reviewing batch manufacturing records (BMRs) for gel products in order to verify completeness, compliance, and readiness for batch release.

2. Scope

This SOP applies to all quality assurance personnel responsible for reviewing batch records related to the manufacturing, packaging, and

testing of gel-based pharmaceutical products.

3. Responsibilities

  • Production Department: Ensures accurate and timely completion of BMRs.
  • Quality Assurance (QA): Performs detailed review of all entries and supporting documentation.
  • Head – QA: Final reviewer for batch release authorization.
See also  Gel Manufacturing: SOP for Filtering Gel Formulations Before Filling - V 2.0

4. Accountability

The QA Head is accountable for ensuring that only compliant and accurately reviewed batch records proceed to batch disposition.

5. Procedure

5.1 Preliminary Collection and Organization

  1. Collect the completed BMR from the production department once the batch is manufactured and packaged.
  2. Ensure all associated IPC records, cleaning logs, line clearance forms, and deviation reports are attached.

5.2 Document Review

  1. Check for completeness:
    • All fields filled and signed
    • No overwriting without proper correction
    • All required forms and checklists are attached
  2. Verify key production parameters like batch size, yield, pH, viscosity, homogenization time, and temperature logs.
  3. Review any deviations, change controls, or incident reports attached to the batch.

5.3 Cross-Verification with Specifications

  1. Compare in-process and final product parameters with product specifications.
  2. Check for any trends or potential batch-to-batch inconsistencies.
  3. Confirm testing reports from QC are attached and match acceptance criteria.
See also  Gel Manufacturing: SOP for Screening Polymers for Gel Development - V 2.0

5.4 Corrections and Clarifications

  1. Highlight discrepancies, missing signatures, or unrecorded steps in a BMR Review Checklist (Annexure-1).
  2. Return BMR to Production for clarification if discrepancies are noted.
  3. Maintain a copy of the communication trail if corrections are made post-batch completion.

5.5 Final Review and Approval

  1. After corrections, QA shall perform a second review to ensure completeness.
  2. QA Head shall sign the BMR approval section indicating the batch is compliant.
  3. Forward approved BMR for final disposition or batch release by Quality Head.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • IPC: In-Process Control
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. Batch Manufacturing Record
  2. BMR Review Checklist – Annexure-1
  3. In-Process Control Record
  4. Line Clearance Checklist
See also  Gel Manufacturing: SOP for In-Process pH Adjustment of Gels - V 2.0

8. References

  • WHO TRS No. 986 Annex 2 – Good Manufacturing Practices
  • ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: BMR Review Checklist

Review Point Yes/No Remarks
All BMR fields completed
Signatures present for all steps
All IPC and QC results attached
No deviations unaccounted
Yield within acceptable range
Corrections justified and initialed
Final QA review complete

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial Issue New SOP QA Head
02/06/2025 2.0 Updated review structure and included checklist format GMP Alignment QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Cleaning of Lyophilizers Post-Batch Processing – V 2.0
Next Post: Analytical Method Development: Development of Environmental Monitoring Plates – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version